Cost-Effectiveness of Hybrid PET/CT for Staging of Non-Small Cell Lung Cancer

Jonas Schreyoegg, Julia Weller, Tom Stargardt, Ken Herrmann, Christina Bluemel, Tobias Dechow, Gerhard Glatting, Bernd J. Krause, Felix Mottaghy, Sven N. Reske, Andreas K. Buck

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1668-1675
JournalJournal of Nuclear Medicine
Volume51
Issue number11
DOIs
Publication statusPublished - Nov 2010

Keywords

  • cost-effectiveness analysis
  • quality-adjusted life year
  • hybrid PET/CT
  • non-small cell lung cancer

Cite this

Schreyoegg, J., Weller, J., Stargardt, T., Herrmann, K., Bluemel, C., Dechow, T., Glatting, G., Krause, B. J., Mottaghy, F., Reske, S. N., & Buck, A. K. (2010). Cost-Effectiveness of Hybrid PET/CT for Staging of Non-Small Cell Lung Cancer. Journal of Nuclear Medicine, 51(11), 1668-1675. https://doi.org/10.2967/jnumed.109.072090